Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia.

Adamičková A, Gažová A, Adamička M, Chomaničová N, Valašková S, Červenák Z, Šalingová B, Kyselovič J

Open source

DOI
10.33549/physiolres.934718
Published
2021 Dec 30
Container
Physiological research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.33549/physiolres.934718,
  title = {Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia.},
  author = {Adamičková A and Gažová A and Adamička M and Chomaničová N and Valašková S and Červenák Z and Šalingová B and Kyselovič J},
  year = {2021},
  journal = {Physiological research},
  doi = {10.33549/physiolres.934718},
  url = {https://doi.org/10.33549/physiolres.934718}
}

RIS

TY  - JOUR
TI  - Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia.
AU  - Adamičková A
AU  - Gažová A
AU  - Adamička M
AU  - Chomaničová N
AU  - Valašková S
AU  - Červenák Z
AU  - Šalingová B
AU  - Kyselovič J
PY  - 2021
JO  - Physiological research
DO  - 10.33549/physiolres.934718
UR  - https://doi.org/10.33549/physiolres.934718
ER  - 

APA

A, A., A, G., M, A., N, C., S, V., Z, Č., B, Š., & J, K. (2021). Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia.. Physiological research. https://doi.org/10.33549/physiolres.934718

Source records